Chagas disease: Coming to a place near you

Dermatologic Clinics

Volumn 29, Issue 1, 2011, Pages 53-62

  Parker, Eva Rawlings ^a   Sethi, Aisha ^b  

^a Franklin Dermatology Group   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

American trypanosomiasis; Chagas disease; Trypanosoma cruzi

Indexed keywords

ALLOPURINOL; ANTIPARASITIC AGENT; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; CLOMIPRAMINE; ITRACONAZOLE; NIFURTIMOX;

ABDOMINAL PAIN; ACUTE DISEASE; ANOREXIA; ARTIFICIAL HEART PACEMAKER; CHAGAS DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL DISORDER; COST OF ILLNESS; DEFIBRILLATOR; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; DYSGEUSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXFOLIATIVE DERMATITIS; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERSENSITIVITY; INFECTION CONTROL; INSOMNIA; LYMPHADENOPATHY; MOOD CHANGE; MYALGIA; NAUSEA; NONHUMAN; PARASITE TRANSMISSION; PARASITE VECTOR; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; POLYNEUROPATHY; PRIORITY JOURNAL; RASH; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SKIN PRURITUS; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TRYPANOSOMA CRUZI; VERTIGO; VOMITING; WEIGHT REDUCTION;

CHAGAS DISEASE; EMIGRATION AND IMMIGRATION; HUMANS; LATIN AMERICA; PREVALENCE; TRYPANOSOMA CRUZI; UNITED STATES;

EID: 78649343056     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2010.08.011     Document Type: Review

References (93)

1. Chagas disease (American trypanosomiasis) Fact Sheet No. 340 World Health Organization website. Available at:, Accessed August 7, 2010. http://www.who.int/mediacentre/factsheets/fs340/en/index.html.
2. Araújo A., Jansen A.M., Reinhard K., et al. Paleoparasitology of Chagas disease-a review. Mem Inst Oswaldo Cruz 2009, 104(Suppl 1):9-16.
3. Rassi A., Rassi A., Marin-Neto J.A. Chagas disease. Lancet 2010, 375:1388-1402.
4. Chagas disease-Detailed FAQs Centers for Disease Control and Prevention website. Available at:, Accessed August 7, 2010. http://www.cdc.gov/chagas/gen_info/detailed.html.
5. Centers for Disease Control and Prevention Blood donor screening for Chagas disease-United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007, 56(7):141-143.
6. Leiby D.A., Herron R.M., Garratty G., et al. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 2008, 198(4):609-613.
7. Bern C., Montgomery S.P., Katz L., et al. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008, 21(5):476-482.
8. Centers for Disease Control and Prevention Chagas disease after organ transplantation-United States, 2001. MMWR Morb Mortal Wkly Rep 2002, 51(10):210-212.
9. Centers for Disease Control and Prevention Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006, 55(29):798-800.
10. Bryan C.F., Tegtmeier G.E., Rafik N., et al. The risk for Chagas' disease in the Midwestern United States organ donor population is low. Clin Transplant 2004, 18(12):12-15.
11. Nowicki M.J., Chinchilla C., Corado L., et al. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk. Transplantation 2006, 81(3):477-479.
12. Pérez-López F.R., Chedraui P. Chagas disease in pregnancy: a non-endemic problem in a globalized world. Arch Gynecol Obstet 2010, [Epub ahead of print].
13. Herwaldt B.L. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 2001, 14(4):659-688.
14. Schmunis G.A. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007, 102(Suppl 1):75-85.
15. Migration and the movement of infectious diseases: Chagas disease Centers for Disease Control and Prevention website. Available at:, Accessed August 7, 2010. http://www.cdc.gov/nczved/framework/features/chagas.html.
16. Kirchhoff L.V. American trypanosomiasis (Chagas' disease)-a tropical disease now in the United States. N Engl J Med 1993, 329:639-644.
17. Altclas J., Jaimovich G., Milovic V., et al. Chagas' disease after bone marrow transplantation. Bone Marrow Transplant 1996, 18(2):447-448.
18. Villalba R., Fornés G., Alvarez M.A., et al. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis 1992, 14(2):594-595.
19. Machado C.M., Martins T.C., Colturato I., et al. Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center. Rev Inst Med Trop Sao Paulo 2009, 51(6):309-324.
20. Chocair P.R., Sabbaga E., Amato Neto V., et al. Kidney transplantation: a new way of transmitting Chagas disease. Rev Inst Med Trop Sao Paulo 1981, 23:280-282.
21. Riarte A., Luna C., Sabatiello R., et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999, 29(3):561-567.
22. Jackson Y., Myers C., Diana A., et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis 2009, 15(4):601-603.
23. Pereira K.S., Schmidt F.L., Barbosa R.L., et al. Transmission of Chagas disease (American trypanosomiasis) by food. Adv Food Nutr Res 2010, 59C:63-85.
24. Nóbrega A.A., Garcia M.H., Tatto E., et al. Oral transmission of Chagas disease by consumption of açaí palm fruit, Brazil. Emerg Infect Dis 2009, 15(4):653-655.
25. Alarcón de Noya B., Díaz-Bello Z., Colmenares C., et al. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis 2010, 201(9):1308-1315.
26. Chagas disease epidemiology & risk factors Centers for Disease Control and Prevention website. Available at:, Accessed August 7, 2010. http://www.cdc.gov/chagas/epi.html.
27. Dorn P., Buekens P., Hanford E. Whac-a-mole: future trends in Chagas transmission and the importance of a global perspective on disease control. Future Microbiol 2007, 2:365-367.
28. Viotti R., Vigliano C.A., Alvarez M.G., et al. The impact of socioeconomic conditions on chronic Chagas disease progression. Rev Esp Cardiol 2009, 62(11):1224-1232.
29. Control of neglected tropical diseases World Health Organization website. Available at:, Accessed August 7, 2010. http://www.who.int/neglected_diseases/en/index.html.
30. Epidemiological profiles of neglected diseases and other infections related to poverty in Latin America and the Caribbean Pan American Health Organization website. Available at:, Accessed August 7, 2010. http://new.paho.org/hq/index.php%3Foption%3Dcom_joomlabook%26Itemid%3D259%26task%3Ddisplay%26id%3D58.
31. Strosberg A.M., Barrio K., Stinger V.H., et al. Chagas disease: a Latin American nemesis. 2007 Institute for OneWorld Health website. Available at:, Accessed August 7, 2010. http://www.oneworldhealth.org/documents/CHAGAS%20Landscape%20FINAL%20VERSION.pdf.
32. Chagas disease in the Americas: no longer exotic 2009 fact sheet Centers for Disease Control and Prevention website. Available at:, Accessed August 7, 2010. http://www.cdc.gov/chagas/resources/chagas_no_longer_an_exotic_disease.pdf.
33. Herwaldt B.L., Grijalva M.J., Newsome A.L., et al. Use of polymerase chain reaction to diagnose the fifth reported U.S. case of autochthonous transmission of Trypanosoma cruzi-Tennessee, 1998. J Infect Dis 2000, 181:395-399.
34. Reisenman C.E., Lawrence G., Guerenstein P.G., et al. Infection of kissing bugs with Trypanosoma cruzi, Tucson, Arizona, USA. Emerg Infect Dis 2010, 16(3):400-405.
35. Barr S.C., Brown C.C., Dennis V.A., et al. The lesions and prevalence of Trypanosoma cruzi in opossums and armadillos from southern Louisiana. J Parasitol 1991, 77:624-627.
36. Yabsley M.J., Noblet G.P. Seroprevalence of Trypanosoma cruzi in raccoons from South Carolina and Georgia. J Wildl Dis 2002, 38(1):75-83.
37. Barr S.C., Dennis V.A., Klei T.R. Serological and blood culture survey of Trypanosoma cruzi infection in four canine populations of southern Louisiana. Am J Vet Res 1991, 52:570-573.
38. Barr S.C., Gossett K.A., Klei T.R. Clinical, clinicopathologic, and parasitologic observations of trypanosomiasis in dogs infected with North American Trypanosoma cruzi isolates. Am J Vet Res 1991, 52:954-960.
39. Burkholder J.E., Allison T.C., Kelly V.P., et al. Chronic Trypanosoma cruzi infection in dogs: 11 cases (1987-1996). J Am Vet Med Assoc 1998, 213:497-500.
40. Beard C.B., Pye G., Steurer F.J., et al. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg Infect Dis 2003, 9(1):103-105.
41. Kjos S.A., Snowden K.F., Craig T.M., et al. Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol 2008, 152(3-4):249-256.
42. Rowland M.E., Maloney J., Cohen S., et al. Factors associated with Trypanosoma cruzi exposure among domestic canines in Tennessee. J Parasitol 2010, 96(3):547-551.
43. Diaz J.H. Chagas disease in the United States: a cause for concern in Louisiana?. J La State Med Soc 2007, 159(1):21-23. 25-9.
44. Hanford E.J., Zhan F.B., Lu Y., et al. Chagas disease in Texas: recognizing the significance and implications of evidence in the literature. Soc Sci Med 2007, 65(1):60-79.
45. Noireau F., Diosque P., Jansen A.M. Trypanosoma cruzi: adaptation to its vectors and its hosts. Vet Res 2009, 40(2):26-28.
46. Dutra W.O., Gollob K.J. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 2008, 21(3):287-292.
47. Scharfstein J., Gomes Jde A., Correa-Oliveira R. Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research. Mem Inst Oswaldo Cruz 2009, 104(Suppl 1):187-198.
48. Teixeira A.R., Nitz N., Guimaro M.C., et al. Chagas disease. Postgrad Med J 2006, 82(974):788-798.
49. Gironès N., Cuervo H., Fresno M. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr Top Microbiol Immunol 2005, 296:89-123.
50. Piacenza L., Alvarez M.N., Peluffo G., et al. Fighting the oxidative assault: the Trypanosoma cruzi journey to infection. Curr Opin Microbiol 2009, 12(4):415-421.
51. Villalta F., Scharfstein J., Ashton A.W., et al. Perspectives on the Trypanosoma cruzi-host cell receptor interactions. Parasitol Res 2009, 104(6):1251-1260.
52. Padilla A.M., Bustamante J.M., Tarleton R.L. CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 2009, 21(4):385-390.
53. Gutierrez F.R., Mineo T.W., Pavanelli W.R., et al. The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 2009, 104(Suppl 1):236-245.
54. Lupi O., Bartlett B.L., Haugen R.N., et al. Tropical dermatology: tropical diseases caused by protozoa. J Am Acad Dermatol 2009, 60:897-925.
55. Rassi A., Rassi A., Rassi S.G. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007, 115(9):1101-1108.
56. Blum J.A., Zellweger M.J., Burri C., et al. Cardiac involvement in African and American trypanosomiasis. Lancet Infect Dis 2008, 8(10):631-641.
57. Bern C., Montgomery S.P., Herwaldt B.L., et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007, 298(18):2171-2181.
58. Matsuda N.M., Miller S.M., Evora P.R. The chronic gastrointestinal manifestations of Chagas disease. Clinics (Sao Paulo) 2009, 64(12):1219-1224.
59. Córdova E., Maiolo E., Corti M., et al. Neurological manifestations of Chagas' disease. Neurol Res 2010, 32(3):238-244.
60. Carod-Artal F.J., Gascon J. Chagas disease and stroke. Lancet Neurol 2010, 9(5):533-542.
61. Ferreira M.S., Nishioka Sde A., Silvestre M.T., et al. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 1997, 25(6):1397-1400.
62. Diazgranados C.A., Saavedra-Trujillo C.H., Mantilla M., et al. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis 2009, 9(5):324-330.
63. Gallerano V., Consigli J., Pereyra S., et al. Chagas' disease reactivation with skin symptoms in a patient with kidney transplant. Int J Dermatol 2007, 46(6):607-610.
64. Hall C.S., Fields K. Cutaneous presentation of Chagas' disease reactivation in a heart-transplant patient in Utah. J Am Acad Dermatol 2008, 58(3):529-530.
65. La Forgia M.P., Pellerano G., de las Mercedes Portaluppi M., et al. Cutaneous manifestation of reactivation of Chagas disease in a renal transplant patient: long-term follow-up. Arch Dermatol 2003, 139(1):104-105.
66. Tomimori-Yamashita J., Deps P.D., Almeida D.R., et al. Cutaneous manifestation of Chagas' disease after heart transplantation: successful treatment with allopurinol. Br J Dermatol 1997, 137(4):626-630.
67. Amato J.G., Amato Neto V., Amato V.S., et al. Cutaneous lesions as the only manifestations of reactions to Trypanosoma cruzi infection in a recipient of a kidney transplant. Rev Soc Bras Med Trop 1996, 30(1):61-63.
68. Libow L.F., Beltrani V.P., Silvers D.N., et al. Post-cardiac transplant reactivation of Chagas' disease diagnosed by skin biopsy. Cutis 1991, 48(1):37-40.
69. Mora M.C., Sanchez Negrette O., Marco D., et al. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology. J Parasitol 2005, 91(6):1468-1473.
70. ORTHO T. cruzi ELISA Test System U.S. Food and Drug Administration website. Available at:, Accessed August 7, 2010. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm085846.htm.
71. Abbott prism Chagas U.S. Food and Drug Administration website. Available at:, Accessed August 7,2010. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm210158.htm.
72. Chagas disease-antiparasitic treatment Centers for Disease Control and Prevention website. Available at:, Accessed August 7, 2010. http://www.cdc.gov/chagas/health_professionals/tx.html.
73. Reyes P.A., Vallejo M. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database Syst Rev 2005, 4. CD004102.
74. Pérez-Molina J.A., Pérez-Ayala A., Moreno S., et al. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J Antimicrob Chemother 2009, 64(6):1139-1147.
75. Viotti R., Vigliano C., Lococo B., et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006, 144(10):724-734.
76. Gobbi P., Baez A., Lo Presti M.S., et al. Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruzi. Parasitol Res 2010, 107(5):127-183.
77. Gobbi P., Lo Presti M.S., Fernández A.R., et al. Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in mice. Parasitol Res 2007, 101(5):1459-1462.
78. Rassi A., Luquetti A.O., Rassi A., et al. Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease. Am J Trop Med Hyg 2007, 76(1):58-61.
79. Apt W., Arribada A., Zulantay I., et al. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment. Ann Trop Med Parasitol 2005, 99(8):733-741.
80. Almeida D.R., Carvalho A.C., Branco J.N., et al. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment. J Heart Lung Transplant 1996, 15(10):988-992.
81. Pinto A.V., de Castro S.L. The trypanocidal activity of naphthoquinones: a review. Molecules 2009, 14(11):4570-4590.
82. Sánchez-Sancho F., Campillo N.E., Páez J.A. Chagas disease: progress and new perspectives. Curr Med Chem 2010, 17(5):423-452.
83. Rivera G., Bocanegra-García V., Ordaz-Pichardo C., et al. New therapeutic targets for drug design against Trypanosoma cruzi, advances and perspectives. Curr Med Chem 2009, 16(25):3286-3293.
84. Ribeiro I., Sevcsik A.M., Alves F., et al. New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl Trop Dis 2009, 3(7):e484.
85. Muratore C.A., Batista Sa L.A., Chiale P.A., et al. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD registry Latin America. Europace 2009, 11(2):164-168.
86. Dubner S., Schapachnik E., Riera A.R., et al. Chagas disease: state-of-the-art of diagnosis and management. Cardiol J 2008, 15(6):493-504.
87. Bestetti R.B., Theodoropoulos T.A. A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease. J Card Fail 2009, 15(3):249-255.
88. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003, 98(5):577-591.
89. Cazorla S.I., Frank F.M., Malchiodi E.L. Vaccination approaches against Trypanosoma cruzi infection. Expert Rev Vaccines 2009, 8(7):921-935.
90. Duschak V.G., Couto A.S. Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem 2009, 16(24):3174-3202.
91. Milei J., Guerri-Guttenberg R.A., Grana D.R., et al. Prognostic impact of Chagas disease in the United States. Am Heart J 2009, 157(1):22-29.
92. Guerri-Guttenberg R.A., Grana D.R., Ambrosio G., et al. Chagas cardiomyopathy: Europe is not spared!. Eur Heart J 2008, 29(21):2587-2591.
93. Milei J., Mautner B., Storino R., et al. Does Chagas' disease exist as an undiagnosed form of cardiomyopathy in the United States?. Am Heart J 1992, 123(6):1732-1735.